5 semaglutide GLP-1 (S) Semaglutide: The benefits and risks

Changes for prescribers to note for 2022 include the prohibition, in-competition, of glucocorticoid (GC) administration by injection and a change to the dosing intervals for salbutamol

This dual-action strategy (increased secretion of the native GLP-1 and increased absorption of a GLP-1 analog) has shown to be effective in a mouse model of T2DM

However, in stark contrast to SYGL-1 and LST-1, Ascl2 and LgR5 functions are not independent of niche signaling: LgR5 enhances Wnt signaling and Ascl2 works with Wnt-dependent transcription factors to induce a stem cell transcriptional signature [53]

doi: 10.1007/s00125-008-1219-1

Members get the full answer, on their own stack